UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.08B |
| 2 |
UBS Group
UBS
|
+$643M |
| 3 |
Southwest Airlines
LUV
|
+$588M |
| 4 |
Medtronic
MDT
|
+$505M |
| 5 |
Workday
WDAY
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.51B |
| 2 |
Tesla
TSLA
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$976M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$803M |
| 5 |
Chevron
CVX
|
+$688M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.79% |
| 2 | Financials | 9.18% |
| 3 | Industrials | 6.66% |
| 4 | Consumer Discretionary | 6.42% |
| 5 | Healthcare | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Ultrapar
UGP
$6.42B
| $11.8M | ﹤0.01% |
2,890,033
+1,643,562
| +132% | +$5.59M |
|
3102
DoubleLine Shiller CAPE US Equities ETF
CAPE
$242M
| $11.8M | ﹤0.01% |
363,525
+29,395
| +9% | +$946K |
|
3103
Viavi Solutions
VIAV
$9.18B
| $11.8M | ﹤0.01% |
931,812
+338,734
| +57% | +$3.73M |
|
3104
Simply Good Foods
SMPL
$956M
| $11.8M | ﹤0.01% |
476,317
+144,495
| +44% | +$4.27M |
|
3105
Mercury Insurance
MCY
$5.92B
| $11.8M | ﹤0.01% |
139,367
+71,090
| +104% | +$5.25M |
|
3106
PUT
Phillips 66
PSX
$86B
| $11.8M | ﹤0.01% |
86,800
-32,600
| -27% | -$4.18M |
|
3107
Oaktree Specialty Lending
OCSL
$1.12B
| $11.8M | ﹤0.01% |
904,340
+62,158
| +7% | +$856K |
|
3108
CALL
Sprott Uranium Miners ETF
URNM
$2B
| $11.8M | ﹤0.01% |
195,200
-77,000
| -28% | -$3.87M |
|
3109
O-I Glass
OI
$1.08B
| $11.8M | ﹤0.01% |
909,435
-134,714
| -13% | -$1.84M |
|
3110
Travere Therapeutics
TVTX
$5.74B
| $11.8M | ﹤0.01% |
493,073
-157,208
| -24% | -$2.96M |
|
3111
American States Water
AWR
$3.43B
| $11.8M | ﹤0.01% |
160,260
+69,508
| +77% | +$5.17M |
|
3112
Cosan
CSAN
$2.68B
| $11.7M | ﹤0.01% |
2,551,244
+109,186
| +4% | +$504K |
|
3113
CALL
Xerox
XRX
$427M
| $11.7M | ﹤0.01% |
3,114,340
-60,100
| -2% | -$266K |
|
3114
Immunovant
IMVT
$8.24B
| $11.7M | ﹤0.01% |
726,173
+54,889
| +8% | +$889K |
|
|
CPRX
3115
DELISTED
Catalyst Pharmaceutical
CPRX
| $11.7M | ﹤0.01% |
593,609
-251,168
| -30% | -$5.17M |
|
3116
Dave Inc
DAVE
$3.94B
| $11.7M | ﹤0.01% |
58,644
-24,424
| -29% | -$5.27M |
|
3117
iShares MSCI Australia ETF
EWA
$1.47B
| $11.7M | ﹤0.01% |
432,491
-28,758
| -6% | -$767K |
|
3118
Amkor Technology
AMKR
$13.1B
| $11.7M | ﹤0.01% |
410,675
-141,500
| -26% | -$3.41M |
|
3119
Olema Pharmaceuticals
OLMA
$1.04B
| $11.7M | ﹤0.01% |
1,190,654
-221,445
| -16% | -$1.33M |
|
3120
Turning Point Brands
TPB
$1.79B
| $11.6M | ﹤0.01% |
117,761
-1,449
| -1% | -$131K |
|
3121
Standex International
SXI
$3.98B
| $11.6M | ﹤0.01% |
54,809
+9,336
| +21% | +$1.76M |
|
3122
Klaviyo
KVYO
$5.09B
| $11.6M | ﹤0.01% |
419,284
-105,846
| -20% | -$3.42M |
|
3123
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.7B
| $11.6M | ﹤0.01% |
284,595
+26,495
| +10% | +$1.02M |
|
3124
iShares US Basic Materials ETF
IYM
$1.03B
| $11.6M | ﹤0.01% |
78,077
-1,296
| -2% | -$189K |
|
|
KW
3125
DELISTED
Kennedy-Wilson Holdings
KW
| $11.6M | ﹤0.01% |
1,390,609
+795,844
| +134% | +$6.38M |
|
Similar funds
UBS Group's Q3 2025 Portfolio in Review
As of Q3 2025, UBS Group held 11,340 positions worth $638B, up 11% from $578B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group's Q3 2025 filing shows 1,170 new, 4,190 increased, 4,486 reduced and 1,079 closed positions. Its largest new stake was Paramount Skydance Corp: 13,287,677 shares worth $251M. The largest sale was NVIDIA, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.
- UBS Group's largest Q3 2025 buy was Paramount Skydance Corp: 13,287,677 shares worth $251M.
- UBS Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $1.08B increase.
- UBS Group's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $1.51B.
- UBS Group fully exited Hess in Q3 2025, selling an estimated $442M.
- UBS Group's ten largest holdings make up 16% of its $638B portfolio in Q3 2025.
- UBS Group opened 1,170 new positions and closed 1,079 in Q3 2025.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $638B.
Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.